Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - OPERATING INCOME
Operating Income AVTX - Avalo Therapeutics, Inc.
-23.4 M
LAST VALUE
46.57%
2 YEAR CAGR
9.82%
5 YEAR CAGR
-6.13%
10 YEAR CAGR